Regeneron Pharmaceuticals Inc (REGN)
843.60
+5.40
(+0.64%)
USD |
NASDAQ |
Nov 01, 16:00
843.60
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price to Book Value: 3.161 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.161 |
| October 31, 2024 | 3.141 |
| October 30, 2024 | 3.458 |
| October 29, 2024 | 3.475 |
| October 28, 2024 | 3.480 |
| October 25, 2024 | 3.496 |
| October 24, 2024 | 3.481 |
| October 23, 2024 | 3.528 |
| October 22, 2024 | 3.614 |
| October 21, 2024 | 3.637 |
| October 18, 2024 | 3.720 |
| October 17, 2024 | 3.748 |
| October 16, 2024 | 3.785 |
| October 15, 2024 | 3.817 |
| October 14, 2024 | 3.808 |
| October 11, 2024 | 3.814 |
| October 10, 2024 | 3.751 |
| October 09, 2024 | 3.801 |
| October 08, 2024 | 3.775 |
| October 07, 2024 | 3.740 |
| October 04, 2024 | 3.803 |
| October 03, 2024 | 3.810 |
| October 02, 2024 | 3.906 |
| October 01, 2024 | 3.931 |
| September 30, 2024 | 3.947 |
| Date | Value |
|---|---|
| September 27, 2024 | 4.075 |
| September 26, 2024 | 4.064 |
| September 25, 2024 | 4.03 |
| September 24, 2024 | 4.088 |
| September 23, 2024 | 4.268 |
| September 20, 2024 | 4.475 |
| September 19, 2024 | 4.495 |
| September 18, 2024 | 4.451 |
| September 17, 2024 | 4.482 |
| September 16, 2024 | 4.506 |
| September 13, 2024 | 4.508 |
| September 12, 2024 | 4.551 |
| September 11, 2024 | 4.461 |
| September 10, 2024 | 4.441 |
| September 09, 2024 | 4.474 |
| September 06, 2024 | 4.422 |
| September 05, 2024 | 4.497 |
| September 04, 2024 | 4.609 |
| September 03, 2024 | 4.568 |
| August 30, 2024 | 4.63 |
| August 29, 2024 | 4.608 |
| August 28, 2024 | 4.687 |
| August 27, 2024 | 4.697 |
| August 26, 2024 | 4.687 |
| August 23, 2024 | 4.686 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.024
Minimum
Sep 06 2022
7.705
Maximum
Jul 20 2020
4.211
Average
3.914
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.80 |
| Eli Lilly and Co | 54.59 |
| Pfizer Inc | 1.815 |
| Biogen Inc | 1.548 |
| Vertex Pharmaceuticals Inc | 8.230 |
Price to Book Value Related Metrics
| PE Ratio | 20.88 |
| PS Ratio | 7.012 |
| PEG Ratio | 1.368 |
| Price to Free Cash Flow | 29.25 |
| Price | 843.60 |
| Earnings Yield | 4.79% |
| Market Cap | 92.70B |
| PEGY Ratio | 1.368 |
| Operating PE Ratio | 23.74 |
| Normalized PE Ratio | 22.04 |